ArticleBMC medical research methodology2026
Rationale for incorporating short-term endpoints in interim futility analysis of phase 3 oncology trials: a simulation study.
Shuhan Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.